 |
|
September 29, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Kate Torchilin, Ph.D., M.B.A., CEO and
President, Mirai Bio |
| In
this CEO Q&A, Torchilin discusses the
delivery bottleneck that inspired Mirai's
founding, what differentiates its
integrated LNP platform, the milestone
that took a partner program from concept
to IND-enabling studies in under ten
months, and leading within the Flagship
Pioneering ecosystem. More |
|
|
- BeyondSpring: FDA Fast Track Designation for
Plinabulin in Post-ICI Non-Squamous NSCLC and
Strategic Transaction to Advance Global Phase
3 DUBLIN-4 Trial Toward Planned Interim
Analysis More
- Cognition Therapeutics: Schedules a Type C
Meeting With FDA to Align on Endpoints for
Phase 3 Trial of Zervimesine (CT1812) in DLB More
- Dianthus Therapeutics: Claseprubart Data
Presentations Planned for 2026 AANEM Annual
Meeting More
- Immuneering: Data at 2026 AACR Conference on
Pancreatic Cancer Supporting Atebimetinib’s
Mechanisms Designed to Extend Survival in
Pancreatic Cancer More
- Montefiore Einstein: Gut Microbiome Changes
Linked to Sickle Cell Disease More
- Mount Sinai: Collaborative Research
Agreement to Evaluate Novel Liquid
Radioembolic Agent for Brain Tumors More
- Novo: Ozempic (Semaglutide) 2 mg Associated
With Lower Risk of Major Adverse
Cardiovascular Events (Death, Heart Attack,
and Stroke) in Adults With Type 2 Diabetes
Compared to Switching to Mounjaro
(Tirzepatide), in Real-World Analysis at EASD
More
- Phathom Pharmaceuticals: Initiation of
Registrational Phase 3 Study of VOQUEZNA
(vonoprazan) for As-Needed Treatment of
Non-Erosive GERD More
- VB Spine: FDA Breakthrough Device
Designation for New Blood Test Designed to
Identify Patients at Risk for Scoliosis
Progression More
|
|
- Definium Therapeutics: New Employee
Inducement Grants More
- More on Merck Licensing a KRAS G12D
Inhibitor for $400M Upfront
More* More*
More
- More on Scynexis Bagging $214M BARDA
Contract for Antifungal Development More
More
More*
More*
- Ortet: Launches as Frontier AI Lab
for Health With $500 Million Commitment From
Thoreau More
More*
- Palatin: Fiscal Year 2026 Financial Results
and Business Update More
- Sampled: Awarded Five-Year, $27.1
Million VA Contract to Support Genomics
Research for the Million Veteran Program More
|
|
 |
| The
future of advanced therapies:
Explore challenges and
opportunities shaping patient
access, site-of-care expansion and
commercialization. |
| Access the
Report → |
|
|
- Big4Bio CEO Weekly Q&A: Kate
Torchilin, Ph.D., M.B.A., CEO and President,
Mirai Bio More
- Biotech & Pharma Updates | September 28,
2026 More
- More on Merck and Daiichi Withdrawing US
Filing for Lung Cancer ADC More*
More*
More
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Biotech Startups Podcast: How Teaching
High School Prepares You to Run a Company
Podcast
|
|
 |
- Aquestive Therapeutics: Strengthens Board of
Directors With Appointment of Richard Daly More
- ICYMI: Anavex Stockholders Elect All of the
Company’s Director Nominees at 2026 Annual
Meeting More
- ICYMI: Chutes & Ladders—Travere Chief
Makes Way for Former Amicus CEO More
- ICYMI: Arthur Hu to Join BD as Chief
Information and Digital Officer More
More
- OPPORTUNITY: Director of Compliance - Remote
More
- OPPORTUNITY: Vice President, Business
Development - Remote More
- Slone Partners: Beyond the Org Chart
- Redefining Leadership Roles After an
Acquisition More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
